Evidence-based treatment options in cannabis dependency;Evidenzbasierte Behandlungsoptionen der Cannabisabhängigkeit

Deutsches Arzteblatt International

Volumn 113, Issue 39, 2016, Pages 653-659

  Walther, Lisa ^a   Gantner, Andreas ^a   Heinz, Andreas ^a   Majic, Tomislav ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS ADDICTION; EVIDENCE BASED MEDICINE; REVIEW; ADOLESCENT; COGNITIVE THERAPY; HUMAN; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CANNABINOID; CANNABIS;

ADOLESCENT; CANNABINOIDS; CANNABIS; COGNITIVE THERAPY; HUMANS; MARIJUANA ABUSE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84991508108     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2016.0653     Document Type: Review

References (40)

1. The Marijuana Treatment Project Research Group: Brief treatments for cannabisdependence: Findings from a randomized multisite trial. J Consult Clin Psychol 2004; 72: 455-66.
2. Kadden RM, Litt MD, Kabela-Cormier E, Petry NM: Abstinence rates following behavioral treatments for marijuana dependence. Addict Behav 2007; 32: 1220-36.
3. Stanger C, Budney AJ, Kamon JL, Thostensen J: A randomized trial of contingency management for adolescent marijuana abuse and dependence. Drug Alcohol Depend 2009; 105: 240-7.
4. Gates PJ, Norberg MM, Copeland J, Digiusto E: Randomized controlled trial of a novel cannabis use intervention delivered by telephone. Addiction 2012; 107: 2149-58.
5. Litt MD, Kadden RM, Petry NM: Behavioral treatment for marijuana dependence: Randomized trial of contingency management and self-efficacy enhancement. Addict Behav 2013; 38: 1764-75.
6. Hoch E, Noack R, Henker J, et al.: Efficacy of a targeted cognitivebehavioral treatment program for cannabis use disorders (CANDIS). Eur Neuropsychopharmacol 2012; 22: 267-80.
7. Hoch E, Bühringer G, Pixa A, et al.: CANDIS treatment program for cannabis use disorders: Findings from a randomized multi-site translational trial. Drug Alcohol Depend 2014; 134: 185-93.
8. Liddle HA: Multidimensional Family Therapy for adolescent cannabis users. Cannabis Youth Treatment (CYT) Series, Volume 5. Rockville, MD: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration 2002.
9. Tossmann P, Jonas B, Rigter H: Multidimensionale Familientherapie (MDFT) bei cannabisbezogenen Störungen. Sucht 2012; 58: 157-66.
10. Rigter H, Henderson CE, Pelc I, et al.: Multidimensional family therapy lowers the rate of cannabis dependence in adolescents: A ran - domised controlled trial in western European outpatient settings. Drug Alcohol Depend 2013; 130: 85-93.
11. Hendriks V, van der Schee E, Blanken P: Treatment of adolescents with a cannabis use disorder: Main findings of a randomized controlled trial comparing multidimensional family therapy and cogni - tive behavioral therapy in The Netherlands. Drug Alcohol Depend 2011; 119: 64-71.
12. Hendriks V, van der Schee E, Blanken P: Matching adolescents with a cannabis use disorder to multidimensional family therapy or cog - nitive behavioral therapy: Treatment effect moderators in a randomiz ed controlled trial. Drug Alcohol Depend 2012; 125: 119-26.
13. Schaub MP, Henderson CE, Pelc I, et al.: Multidimensional family therapy decreases the rate of externalising behavioural disorder symptoms in cannabis abusing adolescents: Outcomes of the INCANT trial. BMC Psychiatry 2014; 14: 26.
14. Martin G, Copeland J: The adolescent cannabis check-up: Randomized trial of a brief intervention for young cannabis users. J Subst Abuse Treat 2008; 34: 407-14.
15. Stephens RS, Roffman RA, Fearer SA, Williams C, Burke RS: The marijuana check-up: Promoting change in ambivalent marijuana users. Addiction 2007; 102: 947-57.
16. Fernandes S, Ferigolo M, Benchaya MC, et al.: Brief motivational intervention and telemedicine: A new perspective of treatment to marij uana users. Addict Behav 2010; 35: 750-5.
17. Walker DD, Stephens R, Roffman R, et al.: Randomized controlled trial of motivational enhancement therapy with nontreatment-seeking adolescent cannabis users: A further test of the teen marijuana check-up. Psychol Addict Behav 2011; 25: 474-84.
18. Stein MD, Hagerty CE, Herman DS, Phipps MG, Anderson BJ: A brief marijuana intervention for non-treatment-seeking young adult women. J Subst Abuse Treat 2011; 40: 189-98.
19. Fischer B, Jones W, Shuper P, Rehm J: 12-month follow-up of an exploratory 'brief intervention' for high-frequency cannabis users among Canadian university students. Subst Abuse Treat Prev Policy 2012; 7: 15.
20. de Dios MA, Herman DS, Britton WB, Hagerty CE, Anderson BJ, Stein MD: Motivational and mindfulness intervention for young adult female marijuana users. J Subst Abuse Treat 2012; 42: 56-64.
21. Lee CM, Kilmer JR, Neighbors C, et al.: Indicated prevention for college student marijuana use: A randomized controlled trial. J Consult Clin Psychol 2013; 81: 702-9.
22. de Gee EA, Verdurmen JE, Bransen E, de Jonge JM, Schippers GM: A randomized controlled trial of a brief motivational enhancement for non-treatment-seeking adolescent cannabis users. J Subst Abuse Treat 2014; 47: 181-8.
23. Rooke S, Copeland J, Norberg M, Hine D, McCambridge J: Effec - tiveness of a self-guided web-based cannabis treatment program: Randomized controlled trial. J Med Internet Res 2013; 15: E26.
24. Tossmann HP, Jonas B, Tensil MD, Lang P, Strüber E: A controlled trial of an internet-based intervention program for cannabis users. Cyberpsychol Behav Soc Netw 2011; 14: 673-9.
25. Schaub MP, Haug S, Wenger A, et al.: Can reduce-The effects of chat-counseling and web-based self-help, web-based self-help alone and a waiting list control program on cannabis use in problem atic cannabis users: A randomized controlled trial. BMC PsychiatrY 2013; 13: 305.
26. Allsop DJ, Copeland J, Lintzeris N, et al.: Nabiximols as an agonist replacement therapy during cannabis withdrawal: A randomized clinical trial. JAMA Psychiatry 2014; 71: 1-11.
27. Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes E V: Dronabinol for the treatment of cannabis dependence: A randomiz - ed, double-blind, placebo-controlled trial. Drug Alcohol Depend 2011; 116: 142-50.
28. Levin FR, McDowell D, Evans SM, et al.: Pharmacotherapy for marijuana dependence: A double-blind, placebo-controlled pilot study of divalproex sodium. Am J Addict 2004; 13: 21-32.
29. Mason BJ, Crean R, Goodell V, et al.: A proof-of-concept randomiz ed controlled study of gabapentin: Effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology 2012; 37: 1689-98.
30. McRae-Clark AL, Carter RE, Killeen TK, et al.: A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend 2009; 105: 132-8.
31. McRae-Clark AL, Baker NL, Gray KM, et al.: Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend 2015; 156: 29-37.
32. Carpenter KM, Mc Dowell D, Brooks DJ, Levin FR: A preliminary trial: Double-blind comparison of nefazodone, bupropion-SR and placebo in the treatment of cannabis dependence. Am J Addict 2009; 18: 53-64.
33. Cornelius JR, Bukstein OG, Douaihy AB, et al.: Double-blind fluoxe - tine trial in comorbid MDD-CUD youth and young adults. Drug Alcohol Depend 2010; 112: 39-45.
34. Kelly MA, Pavlicova M, Glass A, et al.: Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? Drug Alcohol Depend 2014; 144: 42-6.
35. Levin FR, Mariani J, Brooks DJ, et al.: A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for cooccurring cannabis dependence and depressive disorders. Addic - tion 2013; 108: 1084-94.
36. Weinstein A, Miller H, Bluvstein I, et al.: Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: A double-blind placebo-controlled study. Am J Drug Alcohol Abuse 2014; 40: 16-22.
37. Johnston J, Lintzeris N, Allsop DJ, et al.: Lithium carbonate in the management of cannabis withdrawal: A randomized placebo-controlled trial in an inpatient setting. Psychopharmacology (Berl) 2014; 231: 4623-36.
38. Allsop DJ, Bartlett DJ, Johnston J, et al. : The effects of lithium carbonate supplemented with nitrazepam on sleep disturbance during cannabis abstinence. J Clin Sleep Med 2015; 11: 1153-62.
39. Gray KM, Carpenter MJ, Baker NL, et al.: A double-blind randomiz ed controlled trial of n-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry 2012; 169: 805-12.
40. Tossmann P, Gantner A: Frühintervention, Beratung und Behandlung bei Cannabisstörungen. Suchttherapie 2016; 17: 1-5.